Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

14,866

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

14,866 results for “cancer cell”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

ClinicalTrials.gov study NCT04484142. IPD Sharing: YES. Countries: 10. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov study NCT03088540. IPD Sharing: YES. Countries: 24. Publications: 4.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer

ClinicalTrials.gov study NCT02323126. IPD Sharing: YES. Countries: 8. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov study NCT03410108. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

ClinicalTrials.gov study NCT02633800. IPD Sharing: YES. Countries: 7. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT04619004. IPD Sharing: YES. Countries: 16. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov study NCT04644237. IPD Sharing: YES. Countries: 10. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT04205812. IPD Sharing: YES. Countries: 17. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

ClinicalTrials.gov study NCT01828099. IPD Sharing: YES. Countries: 29. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT03599518. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

ClinicalTrials.gov study NCT03596866. IPD Sharing: YES. Countries: 20. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

ClinicalTrials.gov study NCT04478123. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

ClinicalTrials.gov study NCT01685138. IPD Sharing: YES. Countries: 18. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT03505710. IPD Sharing: YES. Countries: 5. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

ClinicalTrials.gov study NCT04154943. IPD Sharing: YES. Countries: 3. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

ClinicalTrials.gov study NCT03255083. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

ClinicalTrials.gov study NCT03626545. IPD Sharing: YES. Countries: 26. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acr

ClinicalTrials.gov study NCT03447769. IPD Sharing: YES. Countries: 41. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

ClinicalTrials.gov study NCT04656652. IPD Sharing: YES. Countries: 26. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2

ClinicalTrials.gov study NCT02733159. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record